Table 2.
Efficacy outcomes of WBFPS, PFWT, TcPO2, ABI and TBI over time
| Group | Baseline | P value | 1 year | P value | 3 years | P value | 5 years | P value | |
|---|---|---|---|---|---|---|---|---|---|
| WBFPS | PBMNCs | 7.60 ± 1.53 | 0.503 | 1.08 ± 2.26 | 0.116 | 0.79 ± 2.55 | 0.508 | 0.78 ± 2.86 | 0.730 |
| PCCs | 7.28 ± 1.81 | 2.13 ± 2.38 | 1.30 ± 2.85 | 1.04 ± 2.42 | |||||
| PFWT, seconds | PBMNCs | 323.7 ± 383.8 | 0.898 | 976.1 ± 385.1 | 0.365 | 992.7 ± 488.4 | 0.894 | 998.2 ± 398.6 | 0.956 |
| PCCs | 308.8 ± 430.3 | 870.6 ± 429.8 | 1010.0 ± 417.4 | 1004.6 ± 410.3 | |||||
| TcPO2, mmHg | PBMNCs | 21.3 ± 12.4 | 0.851 | 28.5 ± 20.7 | 0.487 | 29.0 ± 21.2 | 0.095 | 29.6 ± 20.2 | 0.142 |
| PCCs | 20.6 ± 13.7 | 24.6 ± 18.6 | 20.2 ± 14.8 | 22.4 ± 13.2 | |||||
| ABI | PBMNCs | 0.554 ± 0.222 | 0.230 | 0.692 ± 0.261 | 0.147 | 0.617 ± 0.210 | 0.575 | 0.723 ± 0.200 | 0.631 |
| PCCs | 0.472 ± 0.254 | 0.586 ± 0.247 | 0.657 ± 0.285 | 0.692 ± 0.250 | |||||
| TBI | PBMNCs | 0.174 ± 0.191 | 0.252 | 0.321 ± 0.132 | 0.085 | 0.420 ± 0.308 | 0.407 | 0.438 ± 0.224 | 0.836 |
| PCCs | 0.117 ± 0.155 | 0.268 ± 0.073 | 0.354 ± 0.246 | 0.422 ± 0.312 |
The data are presented as mean ± SD
WBFPS, Wong–Baker Faces Pain Rating Scales; PFWT, pain-free walking time; TcPO2, transcutaneous oxygen pressure; ABI, ankle-brachial index; TBI, toe-brachial index; PBMNC, peripheral blood mononuclear cell; PCC, purified CD34+ cell; SD, standard deviation